Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
365.00    20.00 (5.80%)
Bid:
350.00
Ask:
380.00
Spread: 30.00 (8.571%)
Market Cap: £34.88m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

COVID 19 update

24 Mar 2020 15:57

RNS Number : 4347H
Cropper(James) PLC
24 March 2020
 

 

24 March 2020

 

James Cropper plc

("James Cropper" or the "Company")

COVID 19 update

Given the rapidly changing developments regarding COVID 19, James Cropper issues this update.

Our approach to COVID 19

Our guiding principles on how we are responding to COVID 19 are to:

· protect the health and wellbeing of our employees and their families;

· support our customers; and

· reduce costs and conserve cash to increase our financial resilience

 

Following the governments' lockdown announcement on 23rd March, James Cropper continues to manufacture in all of its locations globally. We have, however, enabled as many people as possible to work from home. We will continue to follow developments closely and will take further action as appropriate.

Financial priorities

As the situation has continued to develop with increasing uncertainty over its impact and duration, our priorities have been to understand better the potential impact on the Company's financial position by stress testing a range of scenarios and to take prompt action to preserve the Company's liquidity. These measures have included, but are not limited to, putting capital expenditure on hold, a hiring freeze and reducing discretionary spend. To provide maximum flexibility, the Company has fully drawn down on its available bank facilities and expects to have approximately £10 million in liquid cash resources at the year end, 28th March 2020.

 

Current trading

 

To date we have not experienced a downturn in demand as a result of COVID 19 and, in respect of the year ending 28 March 2020, we expect to meet market expectations. However, as central governments take further action to contain and delay the spread of the virus, we expect that demand for packaging materials will reduce overall and this would affect our Packaging and Colourform divisions, albeit we foresee an increase in demand for packaging relating to the online retail segment. As regards our TFP division, our current focus is on solving logistical challenges imposed by reducing global airfreight capacity. TFP products are specified into customer programmes, therefore sales are aligned to these markets such as aerospace. These programmes typically have long lives and relatively stable production rates but are controlled by end manufacturers managing sometimes complex supply chains.

 

Dividends

Given the rising level of uncertainty as to how the situation will develop, alongside the other measures we are taking to preserve the Company's cash position, the Board has decided that it would not be prudent to pay a final dividend in respect of the year ending 28 March 2020. We will review the position as regards future dividends later in the year once the outlook becomes clearer. We recognize that this is a significant decision, but the Board believes that it is an appropriate and prudent measure to take at this point as we seek to preserve the Company's financial position through these most uncertain times.

Outlook

 

While the challenges facing our business are unprecedented, our primary concern remains the welfare of our employees, their families and the local communities in which we work.

We have a strong and diversified business and we are taking immediate measures to contain our costs and conserve cash to build resilience.

However, given the continued uncertainty, we do not believe it is possible to retain the Company's 2021 guidance. We will continue to monitor the situation closely and provide further updates as necessary.

 

Enquiries:

James Cropper PLC (AIM: CRPR)

Isabelle Maddock, Group Finance Director

Jim Aldridge, Company Secretary

Tel: +44 (0) 1539 722002

www.jamescropper.com

Shore Capital

Robert Finlay, Henry Willcocks

Anita Ghanekar, John More

Tel: + 44 (0) 207 408 4090

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSEDFILESSEID
Date   Source Headline
14th Apr 20267:00 amRNSFull Year Trading Update
27th Mar 20262:50 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RCollaboration with Hexcel on Composite Recycling
5th Dec 20259:34 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSPCA Shareholdings
17th Nov 20257:00 amRNSInterim Results
5th Nov 20257:00 amRNSNotice of Results and Investor Presentation
20th Oct 20257:00 amRNSCorrection: PDMR and PCA Shareholdings
17th Oct 20254:12 pmRNSPDMR and PCA Shareholdings
15th Sep 20257:00 amRNSDirector/PDMR Shareholding
3rd Sep 20253:34 pmRNSResult of AGM
3rd Sep 20257:00 amRNSAGM Trading Update
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSGrant of Awards under Long-Term Incentive Plan
17th Jul 20257:00 amRNSFull Year Results
15th Jul 20257:00 amRNSNotice of Full Year Results
7th Jul 20257:00 amRNSTrading and Paper & Packaging Customer Update
23rd Jun 20257:00 amRNS-RRecording of Capital Markets Event Presentation
18th Jun 20257:00 amRNSStrategy Update and Capital Markets Event
9th Jun 20257:00 amRNSRevised Terms Agreed for UK Banking Facility
5th Jun 20257:00 amRNS-RNotice of Capital Markets Event
19th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSFull Year Trading Update
1st May 20259:14 amRNS€1.75m sale of non-core IP assets
1st Apr 20257:00 amRNS-RStrategic Collaboration with HOERBIGER
14th Feb 20253:32 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSPDMR and PCA Shareholding
30th Jan 20257:00 amRNSConfirmation of Chief Executive Officer Succession
7th Jan 20257:00 amRNSDirectorate Change
23rd Dec 20249:21 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSInterim Results
4th Nov 202412:03 pmRNSNotification of Major Holdings
1st Nov 20241:05 pmRNSNotice of Interim Results
29th Oct 20247:00 amRNSChief Executive Officer Succession
10th Oct 202410:14 amRNSDirector/PDMR Shareholding
8th Oct 20244:39 pmRNSDirector/PDMR Shareholding
10th Sep 20243:19 pmRNSGrant of Awards under Long-Term Incentive Plan
4th Sep 20244:32 pmRNSResult of Annual General Meeting
4th Sep 20247:00 amRNSAGM Trading Update
5th Aug 202411:56 amRNSNotice of Annual General Meeting
23rd Jul 20247:00 amRNSFull Year Results
22nd Jul 20249:43 amRNSDirectorate Changes
10th Jul 20247:00 amRNSNotice of Full Year Results
14th Jun 202411:00 amRNSAgreement of Bank Covenant Amendments
23rd May 20247:00 amRNSAppointment of MD, Advanced Materials
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.